Actinogen Medical Ltd has released a press release.
UK Regulatory Approval for Alzheimers Clinical Trial-XanADu
Filed with ASX ·
6ix hasn’t read this filing yet.
Actinogen Medical Limited on 6ix
Earlier from Actinogen Medical
- Xanamem Research Published in Prestigious Medical Journal
- Appendix 4C - quarterly
- FDA Approval to Commence Alzheimers Disease Clinical Trial
- Significant Advance in Development of Alzheimers Drug
- FDA Feedback on Xanamem Alzheimers Trail
Later from Actinogen Medical
- Actinogen Medical Financial Results
- TGA Regulatory Approval for Alzheimers Phase II Trial
- March Quarterly Update
- First Patient Treated in Landmark Alzheimers Clinical Trial
- First UK Site Goes Live in Global Alzheimers Clinical Trial
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical